Stay updated with breaking news from Central dr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Story Dr Reddy s to make, sell Eli Lilly s COVID-19 drug Baricitinib in India; 5th drugmaker to do so Dr Reddy s has also tied up with Russian Direct Investment Fund, Russia s sovereign wealth fund that has bankrolled Sputnik V. It has also collaborated with DRDO to develop an anti-Covid drug, 2-deoxy-D-glucose (2-DG), which has also received approval from DCGI BusinessToday.In | May 12, 2021 | Updated 11:31 IST Baricitinib has received restricted emergency use approval from the health ministry s central drugs standard control organisation Dr Reddy s Laboratories has entered into a royalty-free, non-exclusive voluntary licencing agreement with US-based pharma major Eli Lilly and Company for the manufacture and sale of the drug, Baricitinib. Baricitinib has received restricted emergency use approval from the health ministry s central drugs standard control organisation for use in combination with Remdesivir for treatment of suspected or confirmed COVID-19 p ....